Cardiovascular Health Improvement Project
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT02306200
- Status
- Recruiting
Conditions
- Aortic Aneurysm
- Aortic Dissection
- Bicuspid Aortic Valve (BAV)
- Cardiovascular Diseases
- Heart Failure
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
Key Dates
- Start date
- Aug 31, 2013
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2053
- Completion
- Aug 31, 2053
Study Design
- Enrollment
- 15,000 participants (estimated)
Arms
- Arm: Aortic DiseasePatients with a diagnosis of any form of Aortic Disease
- Arm: ControlsPatients without a diagnosis of Aortic Disease
Primary Outcome Measure
Establishing a biobank of patients with Aortic Disease [ Time Frame: 40 years ]
Central Contacts
- Lauren Humphrey-Stark, BS7342324779
- Jen McNamara, MS734-232-6180
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 |
Find similar trials in Ann Arbor, MI
By condition
By specialty
By research site
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic DiseaseRecruiting · The University of Texas Health Science Center, Houston · Newport Beach, California